Metabolic engineering of Escherichia coli for the preparation of C14-enriched monophosphorylated lipid A homologs via an integrated biosynthesis-hydrolysis strategy
Glucopyranosyl lipid adjuvant (GLA) is a potent TLR4 agonist, but access to GLA adjuvants is constrained by complex chemical synthesis. We aimed to establish a biosynthesis-assisted route that combines microbial lipid A pathway engineering with a downstream chemical release step, using naturally derived MPLA as a reference. To minimize structural heterogeneity and direct secondary acylation toward C14, we engineered Escherichia coli by deleting six diversification genes and replacing native lpxL with vplpxL. The resulting C14-enriched LPS precursor was processed using a single mild acid-hydrolysis step, bypassing the conventional alkaline deacylation required for clinical-grade S. minnesota R595-derived MPLA. The purified product, GLA-Cx, was structurally characterized by high-resolution MS/MS and evaluated using complementary structural and impurity-related quality-control readouts (TLC, rFC, and hTLR2); it demonstrated in vitro murine and human TLR4 agonist activity. This process enabled repeatable recovery of 2.0–5.0 g per 35-L batch (57–143 mg L⁻¹), with combined penta- and hexa-acylated fractions of 43.92%–78.06% (61.30 ± 14.69%, mean ± SD, n = 5) of the grouped tetra- to hexa-acylated CAD area, compared with 26.97% for MPLA-SM. We establish an integrated genotype-to-product proof of concept for preparing C14-enriched monophosphorylated lipid A homologs from an engineered microbial cell factory. By combining W3110’s genetic tractability and hexa-acylated lipid A background with C14-directed design, single-step acid release without subsequent alkaline deacylation, and multi-gram recovery, this framework provides a basis for scalable production and quality-control development of complex lipid-based adjuvants.
Authors
- Pu Shan (ORCID: https://orcid.org/0000-0002-6882-5506)
- Xin Li (ORCID: https://orcid.org/0000-0002-7662-1175)
- Xu Wang (ORCID: https://orcid.org/0000-0001-5354-291X)
- Jinyan Chen
- Xinyu Wang
- Yue Li
- Zhibiao Wang
- Shuxiang Li
Institutions
- National Vaccine and Serum Institute (CN)
Publication Details
- Journal
- Microbial Cell Factories
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1186/s12934-026-03172-x
- Primary Topic
- Microbial Metabolic Engineering and Bioproduction
- Type
- article
- Field-Weighted Citation Impact
- 0.00